NVCT โ€“ Nuvectis Pharma Inc. โ€“ 30-Min Long Trade Setup!

26
๐Ÿ“ˆ ๐Ÿš€
๐Ÿ”น Asset: NVCT (NASDAQ)
๐Ÿ”น Timeframe: 30-Min Chart
๐Ÿ”น Setup Type: Ascending Trendline Breakout + Resistance Flip

๐Ÿ“Š Trade Plan (Long Position)
โœ… Entry Zone: Above $10.40 (breakout and close confirmation)
โœ… Stop-Loss (SL): Below $9.77 (trendline support + previous low)

๐ŸŽฏ Take Profit Targets
๐Ÿ“Œ TP1: $11.30 (previous resistance/supply zone)
๐Ÿ“Œ TP2: $12.48 (measured move target / next major resistance)

๐Ÿ“Š Risk-Reward Ratio Calculation
๐Ÿ“‰ Risk (SL Distance):
$10.40 - $9.77 = $0.63 risk per share

๐Ÿ“ˆ Reward to TP1:
$11.30 - $10.40 = $0.90 โ†’ (1.42:1 R/R)

๐Ÿ“ˆ Reward to TP2:
$12.48 - $10.40 = $2.08 โ†’ (3.30:1 R/R)

๐Ÿ” Technical Analysis & Strategy
๐Ÿ“Œ Ascending Support: Price bouncing off rising trendline, forming higher lows
๐Ÿ“Œ Breakout Candle: Strong bullish candle breaking above resistance
๐Ÿ“Œ Volume Consideration: Monitoring for confirmation with rising volume
๐Ÿ“Œ Retest In Progress: Yellow zone previously resistance, now potential support

โš™๏ธ Trade Execution & Risk Management
๐Ÿ“Š Confirm breakout with strong 30-min candle close
๐Ÿ“‰ Trailing Stop Strategy:
Move SL to breakeven after hitting TP1

๐Ÿ’ฐ Partial Profit Booking Strategy
โœ” Book 50% at TP1 = $11.30
โœ” Let the rest ride to TP2 = $12.48
โœ” Trail stop above entry after first target

โš ๏ธ Breakout Failure Risk
โŒ Setup invalid if price falls below $9.77
โŒ Avoid early entry without proper candle close above breakout level

๐Ÿš€ Final Thoughts
โœ” Strong ascending setup with bullish momentum
โœ” Clean breakout with well-defined stop and targets
โœ” Great R/R potential, up to 3.3:1

๐Ÿ”— #NVCT #NASDAQ #BreakoutTrade #ProfittoPath #SwingTrading #StockSetup #TechnicalAnalysis #AscendingSupport #SmartTrading #MomentumStocks

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.